Download Files:
Lck-IN-1
$269
Only 1000 item(s) left in stock.
Products Details
Product Description
– Lck-IN-1 is a potent lymphocyte protein tyrosine kinase (Lck) inhibitor extracted from patent WO2007013673A1, example 48[1].
Web ID
– HY-138202
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C14H15N5
References
– [1]Kazuo Nakai, et al. Fused heterocycles as lck inhibitors. WO2007013673A1.
CAS Number
– 923596-52-5
Molecular Weight
– 253.30
SMILES
– CCCNC1=NN2C(C=C1)=NC=C2C3=CC=NC=C3
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Src
Pathway
– Protein Tyrosine Kinase/RTK
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
